{"entity":{"type":"insider","cik":"0001639972","url":"/insider/0001639972","json_url":"/insider/0001639972.json","name":"Hogan Linda C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":6,"first":"2016-09-07","last":"2017-01-05","span_basis":"filed_date"},"name_variants":[{"name":"Hogan Linda C.","source":"filing","n_filings":6,"first_seen":"2016-09-07","last_seen":"2017-01-05"}],"transactions":[{"id":5010874,"accession":"0000911916-17-000032","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000911916-17-000032","line_url":"/filing/0000911916-17-000032","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1677.0,"shares_display":"1,677","price_per_share":34.59190196779964,"price_display":"34.59","price_state":"stated","total_value":58010.6196,"total_display":"58,010.62","total_whole":"58,011","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-05","filed_date":"2017-01-05","scope":"insider","n_lines":3},{"id":5010852,"accession":"0000911916-17-000032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000911916-17-000032","line_url":"/filing/0000911916-17-000032#line-4","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185.0,"shares_display":"185","price_per_share":36.4,"price_display":"36.40","price_state":"stated","total_value":6734.0,"total_display":"6,734.00","total_whole":"6,734","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-05","scope":"insider"},{"id":5010843,"accession":"0000911916-17-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-17-000032","line_url":"/filing/0000911916-17-000032#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":718.0,"shares_display":"718","price_per_share":36.25,"price_display":"36.25","price_state":"stated","total_value":26027.5,"total_display":"26,027.50","total_whole":"26,028","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2057001,"accession":"0000911916-16-000699","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000911916-16-000699","line_url":"/filing/0000911916-16-000699","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1864.0,"shares_display":"1,864","price_per_share":38.75,"price_display":"38.75","price_state":"stated","total_value":72230.0,"total_display":"72,230.00","total_whole":"72,230","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-05","scope":"insider","n_lines":2},{"id":2056993,"accession":"0000911916-16-000699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000699","line_url":"/filing/0000911916-16-000699#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":719.0,"shares_display":"719","price_per_share":35.2191,"price_display":"35.22","price_state":"stated","total_value":25322.5329,"total_display":"25,322.53","total_whole":"25,323","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":3159440,"accession":"0000911916-16-000689","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000911916-16-000689","line_url":"/filing/0000911916-16-000689#line-4","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1677.0,"shares_display":"1,677","price_per_share":28.5212,"price_display":"28.52","price_state":"stated","total_value":47830.0524,"total_display":"47,830.05","total_whole":"47,830","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-07","scope":"insider"},{"id":3159429,"accession":"0000911916-16-000689","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000689","line_url":"/filing/0000911916-16-000689#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185.0,"shares_display":"185","price_per_share":28.95,"price_display":"28.95","price_state":"stated","total_value":5355.75,"total_display":"5,355.75","total_whole":"5,356","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-04","filed_date":"2016-11-07","scope":"insider"},{"id":2080569,"accession":"0000911916-16-000687","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000687","line_url":"/filing/0000911916-16-000687#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":719.0,"shares_display":"719","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":21570.0,"total_display":"21,570.00","total_whole":"21,570","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-01","filed_date":"2016-11-01","scope":"insider"},{"id":2311439,"accession":"0000911916-16-000678","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000911916-16-000678","line_url":"/filing/0000911916-16-000678#line-6","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1677.0,"shares_display":"1,677","price_per_share":37.08,"price_display":"37.08","price_state":"stated","total_value":62183.16,"total_display":"62,183.16","total_whole":"62,183","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-05","filed_date":"2016-10-05","scope":"insider"},{"id":2311432,"accession":"0000911916-16-000678","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000911916-16-000678","line_url":"/filing/0000911916-16-000678#line-4","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185.0,"shares_display":"185","price_per_share":36.41,"price_display":"36.41","price_state":"stated","total_value":6735.85,"total_display":"6,735.85","total_whole":"6,736","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-04","filed_date":"2016-10-05","scope":"insider"},{"id":2311425,"accession":"0000911916-16-000678","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-16-000678","line_url":"/filing/0000911916-16-000678#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":719.0,"shares_display":"719","price_per_share":37.74,"price_display":"37.74","price_state":"stated","total_value":27135.06,"total_display":"27,135.06","total_whole":"27,135","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":3312604,"accession":"0000911916-16-000654","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000911916-16-000654","line_url":"/filing/0000911916-16-000654","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001639972","owner_name":"Hogan Linda C.","owner_display_name":"Hogan Linda C.","owner_url":"/insider/0001639972","role":"Officer (Head, Bus. Dev. and Strategy)","role_mark":"O","role_mark_label":"Officer (Head, Bus. Dev. and Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head, Bus. Dev. and Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48736.0,"shares_display":"48,736","price_per_share":19.87468323210768,"price_display":"19.87","price_state":"stated","total_value":968612.562,"total_display":"968,612.56","total_whole":"968,613","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-07","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Officer (Head, Bus. Dev. and Strategy)","n_filings":6,"first_seen":"2016-09-07","last_seen":"2017-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001639972","retrieved_at":"2026-08-26T14:43:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}